Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Bioretec Oy (0TN.F) Follow Compare 2.2000 0.0000 (0.00%) As of April 15 at 3:29:01 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0TN.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 0TN.F View More All News Press Releases SEC Filings Bioretec Ltd's Board of Directors has decided on a new option program for the CEO Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH) Bioretec Ltd's Annual Report 2024 published NOTICE OF ANNUAL GENERAL MEETING OF BIORETEC LTD CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec Bioretec Ltd's Financial Statements 2024 published Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth in 2024 - CE mark received in January 2025 Inside information: Bioretec Ltd. receives CE mark approval for RemeOs™ Trauma Screw product portfolio, allowing market launch in Europe Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2025 Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market